Navigation Links
Special Curved Metzenbaum Scissors

ProductsSpecial Curved Metzenbaum Scissors
Company Mediflex Surgical Products
Item Special Curved Metzenbaum Scissors
Features 
  • One-piece or modular
  • Curved
  • 5mm diameter
  • 33cm and 45cm length
  • Insulation
  • Flush ports
  • Rotating shafts
  • Standard stainless steel handles
    • Description The Featured Products are kept in stock at Mediflex and are offered as 1-piece or modular in regular or extra long lengths. All come equipped with insulation, flush ports, rotating shafts, ratchets (where applicable) and standard stainless steel handles.
    Info Mediflex Surgical Products
    Customer Service: (800) 879-7575
    Web site: http://www.mediflex.com/

    Related medicine products :

    1. Specialist Direct Ophthalmoscope
    2. The Natural-Hip Family - Specialty Porous Collared HA
    3. The Natural-Hip Family - Specialty Porous collarless HA
    4. SP-1 Special Procedure Wrap Around Coat Apron.
    5. MSP-3 Special Procedure wrap-around with Integrated Wide Belt
    6. Integra Epilepsy Specialty Electrodes
    7. Special Procedure Apron
    8. Front Closing Special Procedure Apron
    9. O.R. Special Procedure Apron
    10. SPP-1 Special Procedure Poncho Type
    11. O.R. Special Procedure Apron with Collar
    Breaking Medicine Technology:Within3 Expands into Mobile Applications 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program 2American Chemical Societys Weekly PressPac June 3 2009 8740 1American Chemical Societys Weekly PressPac June 3 2009 8740 2American Chemical Societys Weekly PressPac June 3 2009 8740 3American Chemical Societys Weekly PressPac June 3 2009 8740 4American Chemical Societys Weekly PressPac June 3 2009 8740 5American Chemical Societys Weekly PressPac June 3 2009 8740 6American Chemical Societys Weekly PressPac June 3 2009 8740 7American Chemical Societys Weekly PressPac June 3 2009 8740 8American Chemical Societys Weekly PressPac June 3 2009 8740 9American Chemical Societys Weekly PressPac June 3 2009 8740 10Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference 48171 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 1Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 2Video 3A CVS pharmacy Kicks Off 8th Annual ALS Fundraising Campaign in Stores Nationwide 48169 3